Amphastar Pharma (AMPH) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Join SI Premium – FREE
Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.23, $0.22 better than the analyst estimate of $0.01. Revenue for the quarter came in at $68 million versus the consensus estimate of $62.1 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Celestica (CLS) Tops Q1 EPS by 14c
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
